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ABSTRACT
Pharmaceuticals having the hydrazide functional group are an important
division within anti-tuberculosis, anti-parasitic, anti-cancer, and anti-radia-
tion chemotherapeutics. This work presents a colorimetric methodology to
detect and quantify hydrazide based pharmaceuticals. Processes for rapid
spot test, qualitative colorimetric assay, and spectrophotometric quantita-
tive assay are presented. The reagent 2,6-dichloroquinone-4-chloroimine
(Gibbs reagent) is utilized to accomplish the various analytical objectives.
The rapid spot test and qualitative colorimetric assay enables a detection of
hydrazide drugs to a level of 0.0037 grams per milliliter. Quantitative spec-
trophotometric detection of hydrazide drugs is sensitive to a level of 128.2
micrograms per milliliter. The molar absorptivity () is calculated to be 25.32
Liters/(molecm) at 970nm. Inorganic salts and organic compounds were
found not to interfere with colorimetric detection of hydrazide drugs, and
this includes NaBr, NaCl, MgSO4, 2-naphthol, benzoin, p-aminobenzoic acid
various other compounds. Reagents necessary for this methodological
approach are readily available. The colorimetric response of these tests is
readily identified by visual inspection. These methods then are highly sen-
sitive and provide a manner to determine this important type of drugs from
environmental as well as biological origins.
2010 Trade Science Inc. - INDIA
INTRODUCTION
Hydrazide based pharmaceuticals (have the hy-
drazide functional group located on the molecular struc-
ture) are an important group of diversified chemo-thera-
peutics. Examples of this important category of drugs
come from medical areas of anti-tuberculosis, anti-para-
sitic, anti-cancer, and anti-radiation clinical therapeu-
tics. One example that is credited as saving many lives
is isoniazid, a first-line medication/treatment for the bac-
tericidal/bacteriostatic inhibition of tuberculosis[1-3]. Acyl
hydrazides have shown substantial potential for impor-
tant anti-trypanosomal chemotherapeutic agents includ-
ing the treatment for parasitic protist Trypanosoma
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brucei or African Sleeping Sickness[4]. Previous studies
of hydrazide derivatives of wild garlic result in com-
pounds that could function as effective anti-genotoxic
chemotherapeutics for inhibition of clastogenic (mu-
tagenic breakages of chromosomes) aberrations in
vivo[5]. Another considerable potential for novel hy-
drazide base chemotherapeutics is in the area of cancer
treatment. Significant cytotoxic activity against ovarian
cancer is noted for hydrazide based compounds[6]. In
addition, hydrazide based drugs have shown remark-
able anticancer activity toward hormone-dependent and
hormone-independent human cancer cells[7]. Various hy-
drazide based drugs have demonstrated cytotoxicity
against drug-resistant cancer cell lines in combination
therapy[8].
Other studies have shown that salicylhydrazide
compounds demonstrate potent anti-cancer activity
against human cancer cell lines derived from different
origins[9]. The diversified efficacy of hydrazide based
drugs forecasts continued application in clinical are-
nas. Hydrazides have been studied as potential anti-
radiation drugs[10]. A benzoic acid hydrazide transfer-
ring tagged drug was utilized as target-carrier for stud-
ies of human breast cancer[11]. Novel medications that
are hydrazide based are being studied for clinical treat-
ment of excessive fluid retention[12]. In addition, sulfur
based hydrazides have been studied for clinical nutri-
tional modulation and control[13]. These applications
strongly support the necessity of having accurate and
sensitive means to detect and quantify hydrazide based
chemotherapeutics. This work present a rapid spot
test, qualitative colorimetric assay, and a sensitive
spectrophotometric methodology to ascertain hy-
drazide based drugs.
EXPERIMENTAL
Reagents and instruments
All reagents utilized for this study were supplied by
Sigma-Aldrich (P.O.Box 2060, Milwaukee WI, USA).
Gibbs reagent (2,6-dichloroquinone-4-chloroimine)
was acquired through Sigma-Aldrich and was stored
dry until use at -10C. Organic solvents such as ac-
etone was stored in airtight containers over molecular
sieves to remove water. All spectrophotometric mea-
surements were made by Milton Roy Spectronic 21D
using UV/Visible glass cuvettes.
Colorimetric assay methodology
The mixture containing Gibbs reagent 2,6-
dichloroquinone-4-chloroimine is made immediately
before use, kept at room temperature, and made fresh
before each application. An amount of 14 milligrams
2,6-dichloroquinone-4-chloroimine is dissolved into
14.0 milliliters of acetone. Into a reaction tube is placed
100 microliters of water, 100 microliters acetone, fol-
lowed by 60 microliters of prepared Gibbs reagent
O NH
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Figure 1 : Molecular structures of pharmaceuticals utilized in this work are presented having hydrazide functional groups.
The hydrazide functional group is indicated by inset rectangle. Drugs A, B, C, and D were synthesized utilizing microwave
methodology while semicarbazide was used in this study as the spectrophotometric standard.
Positive Negative
Figure 2 : A rapid spot test result demonstrating the use of
Gibbs reagent detection of hydrazide functional groups. Left
tube is positive reaction for the presence of hydrazide drug
(2 milligrams), right side is negative colorimetric response
(no hydrazide drug).
.88 Quantify hydrazide based chemotherapeutic drugs
Current Research Paper
ESAIJ, 5(1) February 2010
An Indian Journal
Environmental Science
microliters of 6 molar NH4OH will produce the posi-
tive brownish-yellow or a negative dark green-yellow
color response.
Assay by spectrophotometer
The spectrophotometric assay of hydrazide phar-
maceuticals is accomplished at wavelength 970nm us-
ing UV/Visible glass cuvettes with a Spectronic 21D
instrument. Test samples to be assayed by spectrom-
eter are first dissolved into acetone previously dried
over molecular sieves. A blank is prepared using ac-
etone dried over molecular sieves. The pharmaceutical
drug samples are dissolved into acetone prior to solu-
bilizing into the reaction mixture. Preparation of the
Gibbs reagent is similar to that of colorimetric assay
(see above). All standards (utilizing semicarbazideHCl)
and pharmaceuticals are prepared similarly. Into three
milliliters of acetone is placed an amount of 500 micro-
liters acetone solution of previously dissolved pharma-
ceutical drug, followed by 350 microliters of Gibbs
regent mixture, and 50 microliters of 6 molar NH4OH.
Fifteen minutes is allowed for optimum colorimetric pro-
duction, then read standards and test samples at 970nm
using dried acetone for adjusting for zero absorbance.
RESULTS & DISCUSSION
Hydrazide based compounds constitute a major cat-
egory of clinical drugs utilized to treat cancer, tubercu-
losis, parasitic infection, liquid retention, and nutritional
mixture, and finally 10 microliters of 6 molar NH4OH
prepared in water. Color reaction begins immediately
and is followed by comparison of test samples to ap-
propriate controls of known hydrazide group concen-
tration. For this study, semicarbazideHCl was utilized
and demonstrated consistent and strong color response.
Rapid spot test
Into 200 microliters of prepared Gibbs reagent (see
above for preparation) is added an equal volume of
test drug dissolved into acetone. The addition of 20
Plate A
Blank 4mg 5mg Blank 1mg 4mg 5mg
Plate B
Blank 3mg 4mg 10mg
Plate C
Figure 3 : The determination of hydrazide class of pharmaceuticals can be accomplished by colorimetric response method
which provides a qualitative value of concentration. Shown here are results of this determination from Plate A: Blank-no drug,
Test sample at 4 milligrams, and known control at 5 milligrams. By comparison to the 5 milligram control, the test sample can
be estimated at about 4 milligrams. Similarly Plat B: Blank-no drug, with known controls at 1 milligram and 5 milligram
permit estimation of unknown sample at 4 milligrams. Similarly Plate C: Blank-no drug, known controls at 3 milligrams and
10 milligrams drug permit assay of test sample at 4 milligrams.
Figure 4 : For spectrophotometric assay of hydrazide drugs
the reaction of Gibbs reagent with hydrazide is quantitative.
Shown is the colorimetric response for the Blank (Gibbs re-
agent plus NH4OH). This method is highly sensitive, demon-
strated by example samples determined to be (A) 128.2 micro-
grams per milliliter and (B) 359.0 micrograms per milliliter.
Assay of hydrazide drugs
Blank A
128.2g/mL
B
359.0g/mL
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health. Having the hydrazide (-C(=O)NHNH2) func-
tional group facilitates a drug structure having a diverse
biological activity. Methods to determine the presence
and amounts of these drugs would be valuable for clini-
cal settings as well as industrial and health care facili-
ties. Gibbs reagent (2,6-dichloroquinone-4-chloro-
imine) will react with, and assay, many para substituted
phenolic based compounds[14-16]. Because of the tre-
mendous importance of hydrazide based anti-tubercu-
losis pharmaceuticals (such as the first-line drug iso-
niazid) for treating and prevention of tuberculosis an
efficient methodology for detection and assay would
be beneficial. A rapid spot test, colorimetric assay, and
spectrophotometric determination of hydrazide based
anti-tuberculosis agents is presented in this work. Sev-
eral hydrazide compounds were synthesized by a mi-
crowave methodology demonstrated previously[17], pre-
sented in figure 1, and were utilized in this work to es-
tablish the efficiency of hydrazide drug determination
by utilizing Gibbs reagent 2,6-dichloroquinone-4-
chloroimine. Drugs A, B, C, and D (Figure 1) each
have a single hydrazide functional group present (indi-
cated by inset rectangle). Drugs A, B, C, and D have
been shown in previous work to be effective inhibitors
of Tuberculosis proliferation[17]. In addition to the hy-
drazide moiety these four drugs have at least one aro-
matic ring. The structure of drugs A, B, and C have a
bromine substituent on the aromatic ring which is shifted
from ortho, to meta, and para position, respectively.
The parent structure of drug D is ciprofloxacin which is
a second generation fluoroquinolone broad-spectrum
antibacterial that inhibits bacterial growth by interfering
with enzymes necessary for DNA unwind and duplica-
tion[18]. In addition to these four drugs the compound
semicarbazide was utilized to establish a sensitive spec-
trophotometric absorbance assay. All reagents are made
fresh before use. Many inorganic and organic com-
pounds were shown to be non-interfering for these colo-
rimetric methods. These compounds are presented in
TABLE 1, and include NaBr, NaCl, MgSO4,
NaH2PO4, salicylic acid, itaconic acid, benzoin, adipic
acid, trans-cinnamic acid, DL-mandelic acid, and p-
aminobenzoic acid as representative assemblage. For
quick identification of hydrazide based pharmaceuti-
cals a colorimetric presumptive test or rapid spot test
has several assets. Notably this type of test are viewed
as: 1) rapid, 2) simple, 3) facile interpretation, and 4)
mobile. An example of a rapid spot test for hydrazide
based drugs is presented in figure 2. The negative event
is a very dark green colorized mixture that is highly dif-
ferentiated from a positive event that can be described
as a yellow-brown or gold outcome. These only two
possible results are contrasted and easily distinguish-
able. This example shows results for only 2 milligrams
of drug. The assay for hydrazide class of pharmaceuti-
cals can be accomplished by a colorimetric response
method which provides a qualitative value of concen-
tration. Several examples of this style is presented in
figure 3. Shown are outcome of this qualitative assay in
Plates A, B, and C. Outcome for Plate A: Blank-no
Determination of hydrazide drugs
Figure 6 : A standard curve for hydrazide based pharmaceuti-
cals shows accuracy and sensitivity to 115 micrograms per
milliliter.
Figure 5 : The absorbance spectra for Gibbs reagent in NH4OH
and hydrazide complex formed upon reaction with Gibbs re-
agent is shown from 370nm to 1000nm. The absorbance
maxima at 970nm from the hydrazide complex is used for
spectrophotometric determination of pharmaceuticals.
Gibbs reagent with NH4OH and hydrazide pharmaceutical
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drug (negative control), a Test sample at 4 milligrams,
and a known positive control at 5 milligrams. By in-
spection using the 5 milligram control, the test sample
can be estimated at about 4 milligrams. Similarly for
Plate B: Blank-no drug (negative control), positive con-
trols at 1 milligram and 5 milligram permit estimation of
the unknown sample at 4 milligrams. Similarly with Plate
C: Blank-no drug (negative control), known controls at
3 milligrams and 10 milligrams drug permit assay of the
test sample at 4 milligrams. Likewise to the rapid spot
test this approach is simple yet produces outcomes that
are highly distinguishable. A spectrophotometric assay
for hydrazide drugs also demonstrates that the chemi-
cal reaction of Gibbs reagent with hydrazide functional
groups is quantitative. Shown in figure 4 is the colori-
metric outcome for the Blank (Gibbs reagent plus
NH4OH) as well as two example standards of known
concentration. This approach is highly sensitive, dem-
onstrated for standard (A) at 128.2 micrograms per
milliliter and standard (B) which is at 359.0 micrograms
per milliliter. For quantitative spectrophotometric assay
it is recommended to enable the analysis at a wave-
length in which the analyte of interest establishes maxi-
mum absorbance contrasted to any foreign interference.
The reaction of Gibbs reagent with NH4OH generates
a dark blue mixture that expresses absorbance through
a broad range of wavelength and is significant through a
large portion of this range. The absorbance spectrum
presented in figure 5 demonstrates the comparison of
Gibbs reagent interaction with NH4OH and the hy-
drazide functional group of hydrazide based pharma-
ceutics. In the range from 370nm to 1000nm the Gibbs
reagent plus NH4OH produces a dark blue mixture that
conflicts with the outcome of the Gibbs reagent plus
hydrazide group. Only in the wavelength range from
930nm to 1000nm does the Gibbs reagent plus hy-
drazide drug generate an overwhelming absorbance
compared to the Gibbs reagent plus NH4OH side re-
action. Therefore the wavelength of 970nm is utilized
for the spectrophotometric quantitative analysis. The
final molar absorptivity () is calculated to be 25.32
Liters/(molecm) at 970nm. A representative standard
curve is visualized in figure 6. Where the standard curve
for hydrazide based pharmaceuticals shows accuracy
and sensitivity to 115 micrograms per milliliter. Linear-
ity is extremely high rendering a Pearson correlation
constant r of 0.9841. The equation of this particular
line becomes: y = 0.0001x + 0.015. The percent re-
covery for pharmaceutical analyte is extremely high from
95% to 105%. The R2, coefficient of determination for
this data is 0.9685, indicating that 96.85% of all vari-
ance in the data is accounted for by the equation. Clearly
the identification of hydrazide based pharmaceuticals
can by done accurately and consistently by reaction
with Gibbs reagent. The methodologies presented in
this study will find considerable efficacy for environ-
mental related applications where it is necessary to iden-
tify and quantify drugs that bear the hydrazide func-
tional group.
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